Potential safety concerns of Avastin for ROP considered

BOSTON — There is increasing reason to consider potential safety concerns of Avastin therapy for retinopathy of prematurity, according to a speaker here.Citing accumulating evidence, Robert Avery, MD, told colleagues at the American Society of Retina Specialists meeting that studies show there are systemic effects associated with the treatment.

Full Story →